FULL POSTER SESSION ABSTRACTSbehind its continued secretion by white cells is intriguing. One likely candidate is farnesol because opaque cells, unlike white cells, do not accumulatedetectable levels of farnesol. Macrophages are capable of detecting and responding to exogenous farnesol. Earlier our group reported that farnesolstimulates the expression of both pro-inflammatory and regulatory cytokines by mouse macrophage. The production of these warning signals is animportant indicator of how the body ultimately hopes to clear the infection. Others have shown that farnesol suppresses the anti-Candida activity ofmacrophages through its cytotoxic effects, thus making it all the more difficult to eliminate the fungus early in infection. Here we report the in vitro role offarnesol and other known QSM in macrophage chemotaxis and relative phagocytosis of C. albicans.499. The Role of ISW2 for in vitro and in vivo Chlamydospore Production in Candida albicans. Ruvini U. Pathirana 1 , Dhammika H. M. L. P. Navarathna 2 ,David D. Roberts 2 , Kenneth W. Nickerson 1 . 1) School of Biological Sciences, University of Nebraska - Lincoln, Lincoln, NE; 2) Laboratory of Pathology, Centerfor Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.The production of chlamydospores is an unusual feature in the medically important opportunistic pathogen Candida albicans which is commonly used asan in vitro diagnostic tool. These thick walled spherical structures arise from a filament tip which is termed a suspensor cell. In the process of evolution, itis hard to believe that C.albicans makes a spore that does not contribute to its biology and thus the function of chlamydospores is of interest. Upon carefulobservation of the chronic stage of C.albicans colonization in mouse kidneys, we often find large cells similar in appearance to chlamydospores. Wecharacterized these large cells using sucrose density gradients and compared them with in vitro induced chlamydospores. The in vivo cells had the samebuoyancy and were physiologically similar to in vitro chlamydospores. So we hypothesized that chlamydospores may promote the persistence of thesepathogens during pathogenesis, particularly in kidneys. To test the role of chlamydospores during host infection, we used the wild type strain SC5314 andcreated a ISW2 knock out mutant. An ISW2 knock out had been reported to be completely abolish chlamydospore formation. We found that the ISW2mutant had significantly reduced virulence in mouse model of disseminated candidiasis and also failed to induce chlamydospores in mouse kidneys duringpathogenesis . In vitro studies confirm the ability of these mutants for normal filamentous growth, but they failed to produce typical chlamydospores fromsuspensor cells. However, after three weeks they produced chlamydospore-like structures that differed from normal chlamydospore production by thecomplete absence of suspensor cells. As an essential ATP dependent chromatin remodeling factor in yeasts, ISW2 affects the regulation of transcription,recombination, and DNA repair. Our findings suggest that ISW2 may also down regulate the genes for suspensor cell formation but not the genes forchlamydospore formation indicating that these are two independent processes. Further, our investigation into in vivo role of chlamydospores andsuspensor cells suggest that ISW2 could be a future drug target. Further studies on gene regulation by ISW2 in C.albicans will be paramount to ourunderstanding of development and regulatory steps for chlamydospore formation and their contribution to host infection.500. Nutrient immunity and systemic readjustment of metal homeostasis modulate fungal iron availability during the development of renal infections.Joanna Potrykus 1 , David Stead 2 , Dagmar S Urgast 3 , Donna MacCallum 1 , Andrea Raab 3 , Jörg Feldmann 3 , Alistair JP Brown 1 . 1) Aberdeen <strong>Fungal</strong> Group,University of Aberdeen, Aberdeen, United Kingdom; 2) Aberdeen Proteomics, University of Aberdeen, Aberdeen, United Kingdom; 3) Trace ElementSpeciation Laboratory, University of Aberdeen, Aberdeen, United Kingdom.Iron is a vital micronutrient that can limit the growth and virulence of many microbial pathogens. Here we show, that in the murine model ofdisseminated candidiasis, the dynamics of iron availability are driven by a complex interplay of localized and systemic events. As the infection progresses inthe kidney, Candida albicans responds by broadening its repertoire of iron acquisition strategies from non-heme iron (FTR1-dependent) to heme-ironacquisition (HMX1-dependent), as demonstrated in situ by laser capture microdissection, RNA amplification and qRT-PCR. This suggested changes in ironavailability in the vicinity of fungus. This was confirmed by 56 Fe iron distribution mapping in infected tissues via laser ablation-ICP-MS, which revealeddistinct iron exclusion zones around the lesions. These exclusion zones correlated with the immune infiltrates encircling the fungal mass, and wereassociated with elevated concentrations of murine heme oxygenase (HO-1) circumventing the lesions. Also, MALDI Imaging revealed an increase in hemeand hemoglobin alpha levels in the infected tissue, with their distribution roughly corresponding to that of 56 Fe. Paradoxically, whilst iron was excludedfrom lesions, there was a significant increase in the levels of iron in the kidneys of infected animals. This iron appeared tissue bound, was concentratedaway from the fungal exclusion zones, and was accompanied by increased levels of ferritin and HO-2. This iron accumulation in the kidney correlated withdefects in red pulp macrophage function and red blood cell recycling in the spleen, brought about by the fungal infection. Significantly, this effect could bereplicated by selective chemical ablation of splenic red pulp macrophages by clodronate. Collectively, our data indicate that systemic events shapemicronutrient availability within local tissue environments during fungal infection. The infection attenuates the functionality of splenic red pulpmacrophages leading to elevated renal involvement in systemic iron homeostasis and increased renal iron loading. Simultaneously, localized nutrientimmunity limits iron availability around foci of fungal infection in the kidney. In response, the fungus modulates its iron assimilation strategies.501. Identification of the gut fungi in humans with nonconventional diets. Mallory Suhr, Heather Hallen-Adams. Food Science and Technology,University of Nebraska-Lincoln, Lincoln, NE.Identification of the microorganisms that establish themselves inside and outside the human body is crucial to explore how the microbiome impactshuman health. The recent Human Microbiome Project provides an initial compilation and identification of the gut microbiome ecosystem. It is wellresearched and understood that a large part of the gastrointestinal microbiota spans across the prokaryotic domain, but few studies have investigated thecontribution of fungi to the human gut microbiome. Factors such as diet, genetics, and environment can play an influential role in explaining whydifferences in microbiota exist between human hosts. Expanding on work from our lab, this study examines the effect of nonconventional diets (e.g.vegetarians, vegans, gluten-free and lactose-free) on the GI tract fungi. DNA from fecal samples of healthy human subjects was isolated and fungal-specificITS primers were used to target fungal DNA to obtain a baseline of data for gut fungi. Candida tropicalis and C. albicans were both detected, with C.tropicalis more prevalent. This relative abundance of C. tropicalis is in keeping with our earlier studies in people with conventional diets, and may be aregional phenomenon.502. The mutational landscape of gradual acquisition of drug resistance in clinical isolates of Candida albicans. Jason Funt 1 , Darren Abbey 7 , Luca Issi 5 ,Brian Oliver 3 , Theodore White 4 , Reeta Rao 5 , Judith Berman 6 , Dawn Thompson 1 , Aviv Regev 1,2 . 1) Broad Institute of MIT and Harvard, 7 Cambridge Center,Cambridge, MA 02142; 2) Howard Hughes Medical Institute, Department of Biology, Massachusetts Institute of Technology, 77 Masscahusetts Ave,Camridge, MA 02140; 3) Seattle Biomedical Research Institute, Seattle, WA; 4) School of Biological Sciences, University of Missouri at Kansas City, MS; 5)Worcester Polytechnic Institute, Department of Biology and Biotechnology, 100 Institute Road, Worcester MA 01609; 6) Tel Aviv University, Ramat Aviv,69978 Israel; 7) University of Minnesota, Minneapolis MN 55455 USA.Candida albicans is both a member of the healthy human microbiome and a major pathogen in immunocompromised individuals1. Infections are most244
FULL POSTER SESSION ABSTRACTScommonly treated with azole inhibitors of ergosterol biosynthesis. Prophylactic treatment in immuncompromised patients2,3 often leads to thedevelopment of drug resistance. Since C. albicans is diploid and lacks a complete sexual cycle, conventional genetic analysis is challenging. An alternativeapproach is to study the mutations that arise naturally during the evolution of drug resistance in vivo, using isolates sampled consecutively from the samepatient. Studies in evolved isolates have implicated multiple mechanisms in drug resistance, but have focused on large-scale aberrations or candidategenes, and do not comprehensively chart the genetic basis of adaptation5. Here, we leveraged next-generation sequencing to systematically analyze 43isolates from 11 oral candidiasis patients, collected sequentially at two to 16 time points per patient. Because most isolates from an individual patientwere clonal, we could detect newly acquired mutations, including single-nucleotide polymorphisms (SNPs), copy-number variations and loss ofheterozygosity (LOH) events. Focusing on new mutations that were both persistent within a patient and recurrent across patients, we found that LOHevents were commonly associated with acquired resistance, and that persistent and recurrent point mutations in over 150 genes may be related to thecomplex process of adaptation to the host. Conversely, most aneuploidies were transient and did not directly correlate with changes in drug resistance.Our work sheds new light on the molecular mechanisms underlying the evolution of drug resistance and host adaptation.503. Yeast-Hypha transition and immune recognition of Candida albicans influenced by defects in cell signal transduction pathways. Pankaj Mehrotra,Rebecca A Hall, Jeanette Wagener, Neil A.R. Gow. Aberdeen <strong>Fungal</strong> Group, Aberdeen.During the infection process C. albicans has to respond to various stresses imposed by the host environment including oxidative and osmolarity stressgenerated by phagocytic cells such as macrophages and neutrophils, and also the cell wall stress agents such as exposure to caspofungin and otherantifungal antibiotics. These stress responses area orchestrated through the activation of multiple stress pathways including the cAMP-PKA, several MAPKpathways and the Ca 2+ -calcineurin pathway influence the cell wall shape and composition. We are investigating the effect of the activation or inhibition ofthese pathways on immune recognition mechanisms. We therefore determined the importance of the MAPK, cAMP-PKA and Ca 2+ -calcineurin pathways onthe fungal innate immune response by examining uptake, phagocytosis, and cytokine profile induced by mononuclear and polynuclear lymphocytes inresponse to a library of mutants in each of the above pathways under stressed and non-stressed conditions. We find that the activation and inhibition ofthese pathways plays a important role in remodeling of cell wall and hence the immunological profile. For example, deletion of TPK1 and CNA1 resulted inlower pro-inflammatory cytokine production. Immune- recognition was also affected by the exposure of C. albicans signaling mutants with Calcofluorwhite,caspofungin , oxidative and osmotic stress and changes in temperature. These results suggest that stress signaling pathways act in a co-ordinatedfashion to regulate yeast-hypha morphogenesis and the changes in the cell wall which in turn affects the immunological signature of the cell. Thusexposure to different microenvironments significantly modifies the immunological response to fungal cells, suggesting that responses to local stressesmakes the fungal cell surface is a moving target for immunological surveillance.504. GPI PbPga1 of Paracoccidioides brasiliensis is a surface antigen that activates macrophages and mast cells through the NFkB signaling pathway. C.X. R. Valim, L. K. Arruda, P. S. R. Coelho, C. Oliver, M. C. Jamur. Faculdade de Medicina de Ribeirão Preto, USP, Ribeirão Preto, São Paulo, Brazil.Paracoccidioides brasiliensis is the etiologic agent of paracoccidioidomycosis (PCM), one of the most prevalent mycosis in Latin America. P. brasiliensiscell wall components interact with host cells and influence the pathogenesis of PCM. PbPga1 is a GPI anchored protein that is up-regulated in the yeastpathogenic form. GPI anchored proteins are involved in cell-cell and cell-tissue adhesion and have a key role in the interaction between fungal and hostcells. PbPga1 is an O-glycosylated protein that is localized on the yeast cell surface. Recombinant PbPga1 (rPbPga1) induces nitric oxide (NO) productionand TNF-a release in murine peritoneal macrophages (Valim et al.Plos One, 2012). In the present study, rPbPga1 was able to activate NFkB in macrophagelikeRaw cells that had been transfected with NFkB luciferase as well as in a reporter cell line for NFkB activation derived from RBL-2H3 mast cells. Theresults show that like macrophages, rPbPga1 also activates the transcription factor NFkB in mast cells. However, rPbPga1 does not activate NFAT nor is itable to induce liberation of beta hexosaminidase . The lack of beta hexosaminidase release suggests the PbPga1 is not able to activate RBL-2H3 mast cellsvia the high affinity IgE receptor. Mast cell activation by rPbPga1 does result in activation of the transcription factor NFkB suggesting stimulation ofcytokine production. Taken together these results indicate that the surface antigen PbPga1 may play an important role in PCM pathogenesis by activatingmacrophages and mast cells.505. Cladosporium fulvum effector Ecp6 outcompetes host immune receptor for chitin binding through intrachain LysM dimerization. Andrea Sánchez-Vallet 1 , Raspudin Saleem-Batcha 2 , Anja Kombrink 1 , Guido Hansen 2 , Dirk-Jan Valkenburg 1 , Jeroen R. Mesters 2 , Bart P.H.J. Thomma 1 . 1) Laboratory ofPhytopathology, Wageningen University, Wageningen, Netherlands; 2) Institute of Biochemistry, Center for Structural and Cell Biology in Medicine,University of Lübeck, Lübeck, Germany.Successful pathogens secrete effector proteins to deregulate host immunity which is triggered upon detection of pathogen-associated molecularpatterns (PAMPs). Several fungal pathogens employ LysM effectors, such as Ecp6 from Cladosporium fulvum, to sequester fungal cell wall-derived chitinoligomers which act as PAMP and would otherwise be recognized by host immune receptors and trigger defense responses. The mechanism by whichLysM effectors scavenge chitin molecules remained unknown thus far. Based on crystal structure analysis of Ecp6, we reveal a novel mechanism for chitinbinding by intrachain LysM dimerization, leading to a binding groove in which chitin is deeply buried in the effector protein. Isothermal titrationcalorimetry experiments show that the concerted action of two LysM domains mediates a single chitin binding event with ultra-high (pM) affinity.506. Genotypic and phenotypic characterization of Setosphaeria turcica reveals population diversity and a candidate virulence gene location. SantiagoMideros 1 , Chia-Lin Chung 1,3 , Jesse Poland 2,4 , Gillian Turgeon 1 , Rebecca Nelson 1,2 . 1) Cornell University, Dept. of Plant Pathology and Plant-Microbe Biology,Ithaca, NY, USA; 2) Cornell University, Dept. of Plant Breeding and <strong>Genetics</strong>, Ithaca, NY, USA; 3) National Taiwan University, Dept. of Plant Pathology andMicrobiology, Taipei, Taiwan; 4) USDA-ARS, Hard Winter Wheat <strong>Genetics</strong> Research Unit, Kansas State University, Manhattan, KS, USA.The dothideomycete maize pathogen Setosphaeria turcica (anamorph Exserohilum turcicum) causes Northern Leaf Blight, one of the most commonfungal diseases of maize worldwide. Little is known about the genetic basis of virulence and aggressiveness in this pathogen, although several races havebeen described based on their compatibility with maize resistance genes Ht1, Ht2, Ht3 and HtN. To study the genetic basis of virulence and aggressiveness,we generated a F1 population consisting of 221 monosporic progeny of a cross between a race 1 strain and a race 23N strain. Genotyping-by-sequencing(GBS) was conducted on the population and an additional 13 diverse isolates that included the parental lines. We obtained between 341,000 and 428,000sequence tags for each of the 234 isolates. Alignment to the S. turcica Et28A v1.0 genomic sequence(http://genome.jgi.doe.gov/Settu1/Settu1.home.html) yielded 27,174 single nucleotide polymorphisms (SNPs) at a density of 0.63 SNPs per kb. In the 13isolates, using 9,526 filtered SNPs, we found an average nucleotide diversity (p) of 0.297. Using 564 polymorphic markers with less than 35% missing calls,we created a high-density genetic map that resulted in 23 linkage groups and a total length of 1,686 cM. The Et28A sequence has 407 scaffolds, fourscaffolds formed a single linkage group in our genetic map. The rest of the genome remains fragmented. To identify genomic regions controlling virulence<strong>27th</strong> <strong>Fungal</strong> <strong>Genetics</strong> <strong>Conference</strong> | 245
- Page 1:
Asilomar Conference GroundsMarch 12
- Page 7 and 8:
SCHEDULE OF EVENTSFriday, March 157
- Page 10 and 11:
EXHIBITSThe following companies hav
- Page 12 and 13:
CONCURRENT SESSIONS SCHEDULESWednes
- Page 14:
CONCURRENT SESSIONS SCHEDULESWednes
- Page 17 and 18:
CONCURRENT SESSIONS SCHEDULESThursd
- Page 19:
CONCURRENT SESSIONS SCHEDULESFriday
- Page 22 and 23:
CONCURRENT SESSIONS SCHEDULESSaturd
- Page 24:
CONCURRENT SESSIONS SCHEDULESSaturd
- Page 27 and 28:
PLENARY SESSION ABSTRACTSThursday,
- Page 29 and 30:
PLENARY SESSION ABSTRACTSFriday, Ma
- Page 31 and 32:
PLENARY SESSION ABSTRACTSSaturday,
- Page 33 and 34:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 35 and 36:
CONCURRENT SESSION ABSTRACTSUnravel
- Page 37 and 38:
CONCURRENT SESSION ABSTRACTSSynergi
- Page 39 and 40:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 41 and 42:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 43 and 44:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 45 and 46:
CONCURRENT SESSION ABSTRACTSA draft
- Page 47 and 48:
CONCURRENT SESSION ABSTRACTSRegulat
- Page 49 and 50:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 51 and 52:
CONCURRENT SESSION ABSTRACTSThursda
- Page 53 and 54:
CONCURRENT SESSION ABSTRACTSThursda
- Page 55 and 56:
CONCURRENT SESSION ABSTRACTSThursda
- Page 57 and 58:
CONCURRENT SESSION ABSTRACTSThursda
- Page 59 and 60:
CONCURRENT SESSION ABSTRACTSThursda
- Page 61 and 62:
CONCURRENT SESSION ABSTRACTSThe mut
- Page 63 and 64:
CONCURRENT SESSION ABSTRACTSInnate
- Page 65 and 66:
CONCURRENT SESSION ABSTRACTSThursda
- Page 67 and 68:
CONCURRENT SESSION ABSTRACTSGenome-
- Page 69 and 70:
CONCURRENT SESSION ABSTRACTSIdentif
- Page 71 and 72:
CONCURRENT SESSION ABSTRACTSFriday,
- Page 73 and 74:
CONCURRENT SESSION ABSTRACTSFriday,
- Page 75 and 76:
CONCURRENT SESSION ABSTRACTSThe Scl
- Page 77 and 78:
CONCURRENT SESSION ABSTRACTSThe rol
- Page 79 and 80:
CONCURRENT SESSION ABSTRACTSFriday,
- Page 81 and 82:
CONCURRENT SESSION ABSTRACTSCompari
- Page 83 and 84:
CONCURRENT SESSION ABSTRACTSNovel t
- Page 85 and 86:
CONCURRENT SESSION ABSTRACTSFriday,
- Page 87 and 88:
CONCURRENT SESSION ABSTRACTSEffect
- Page 89 and 90:
CONCURRENT SESSION ABSTRACTSCommon
- Page 91 and 92:
CONCURRENT SESSION ABSTRACTSSaturda
- Page 93 and 94:
CONCURRENT SESSION ABSTRACTSSeconda
- Page 95 and 96:
CONCURRENT SESSION ABSTRACTSSheddin
- Page 97 and 98:
CONCURRENT SESSION ABSTRACTSSaturda
- Page 99 and 100:
CONCURRENT SESSION ABSTRACTSSaturda
- Page 101 and 102:
CONCURRENT SESSION ABSTRACTSSaturda
- Page 103 and 104:
CONCURRENT SESSION ABSTRACTSprocess
- Page 105 and 106:
CONCURRENT SESSION ABSTRACTSSpecifi
- Page 107 and 108:
LISTING OF ALL POSTER ABSTRACTSBioc
- Page 109 and 110:
LISTING OF ALL POSTER ABSTRACTS81.
- Page 111 and 112:
LISTING OF ALL POSTER ABSTRACTS160.
- Page 113 and 114:
LISTING OF ALL POSTER ABSTRACTS239.
- Page 115 and 116:
LISTING OF ALL POSTER ABSTRACTS322.
- Page 117 and 118:
LISTING OF ALL POSTER ABSTRACTS401.
- Page 119 and 120:
LISTING OF ALL POSTER ABSTRACTSmedi
- Page 121 and 122:
LISTING OF ALL POSTER ABSTRACTS558.
- Page 123 and 124:
LISTING OF ALL POSTER ABSTRACTS640.
- Page 125 and 126:
LISTING OF ALL POSTER ABSTRACTS723.
- Page 127 and 128:
FULL POSTER SESSION ABSTRACTS5. Cha
- Page 129 and 130:
FULL POSTER SESSION ABSTRACTS13. In
- Page 131 and 132:
FULL POSTER SESSION ABSTRACTSbioche
- Page 133 and 134:
FULL POSTER SESSION ABSTRACTS30. Me
- Page 135 and 136:
FULL POSTER SESSION ABSTRACTS38. Me
- Page 137 and 138:
FULL POSTER SESSION ABSTRACTSidenti
- Page 139 and 140:
FULL POSTER SESSION ABSTRACTSsecret
- Page 141 and 142:
FULL POSTER SESSION ABSTRACTSinvolv
- Page 143 and 144:
FULL POSTER SESSION ABSTRACTSdiploi
- Page 145 and 146:
FULL POSTER SESSION ABSTRACTSSaccha
- Page 147 and 148:
FULL POSTER SESSION ABSTRACTSresist
- Page 149 and 150:
FULL POSTER SESSION ABSTRACTS96. Ce
- Page 151 and 152:
FULL POSTER SESSION ABSTRACTS104. M
- Page 153 and 154:
FULL POSTER SESSION ABSTRACTScan ex
- Page 155 and 156:
FULL POSTER SESSION ABSTRACTSturgor
- Page 157 and 158:
FULL POSTER SESSION ABSTRACTSlike p
- Page 159 and 160:
FULL POSTER SESSION ABSTRACTSIndoor
- Page 161 and 162:
FULL POSTER SESSION ABSTRACTSlength
- Page 163 and 164:
FULL POSTER SESSION ABSTRACTSA scre
- Page 165 and 166:
FULL POSTER SESSION ABSTRACTSthen q
- Page 167 and 168:
FULL POSTER SESSION ABSTRACTS170. S
- Page 169 and 170:
FULL POSTER SESSION ABSTRACTSof sup
- Page 171 and 172:
FULL POSTER SESSION ABSTRACTSis fzo
- Page 173 and 174:
FULL POSTER SESSION ABSTRACTSgrowth
- Page 175 and 176:
FULL POSTER SESSION ABSTRACTSSeq da
- Page 177 and 178:
FULL POSTER SESSION ABSTRACTS212. T
- Page 179 and 180:
FULL POSTER SESSION ABSTRACTSCompar
- Page 181 and 182:
FULL POSTER SESSION ABSTRACTSmore g
- Page 183 and 184:
FULL POSTER SESSION ABSTRACTSmolecu
- Page 185 and 186:
FULL POSTER SESSION ABSTRACTSunexpe
- Page 187 and 188:
FULL POSTER SESSION ABSTRACTSrapid
- Page 189 and 190:
FULL POSTER SESSION ABSTRACTS260. T
- Page 191 and 192:
FULL POSTER SESSION ABSTRACTSFusari
- Page 193 and 194:
FULL POSTER SESSION ABSTRACTSScienc
- Page 195 and 196:
FULL POSTER SESSION ABSTRACTS286. G
- Page 197 and 198: FULL POSTER SESSION ABSTRACTSincomp
- Page 199 and 200: FULL POSTER SESSION ABSTRACTSfound
- Page 201 and 202: FULL POSTER SESSION ABSTRACTS312. I
- Page 203 and 204: FULL POSTER SESSION ABSTRACTSall th
- Page 205 and 206: FULL POSTER SESSION ABSTRACTSPia La
- Page 207 and 208: FULL POSTER SESSION ABSTRACTS335. A
- Page 209 and 210: FULL POSTER SESSION ABSTRACTS342. F
- Page 211 and 212: FULL POSTER SESSION ABSTRACTSThis i
- Page 213 and 214: FULL POSTER SESSION ABSTRACTSJacobs
- Page 215 and 216: FULL POSTER SESSION ABSTRACTScalciu
- Page 217 and 218: FULL POSTER SESSION ABSTRACTSThe ab
- Page 219 and 220: FULL POSTER SESSION ABSTRACTSexpres
- Page 221 and 222: FULL POSTER SESSION ABSTRACTS394. F
- Page 223 and 224: FULL POSTER SESSION ABSTRACTS398. U
- Page 225 and 226: FULL POSTER SESSION ABSTRACTSthe id
- Page 227 and 228: FULL POSTER SESSION ABSTRACTS415. A
- Page 229 and 230: FULL POSTER SESSION ABSTRACTSAcuM b
- Page 231 and 232: FULL POSTER SESSION ABSTRACTSdiverg
- Page 233 and 234: FULL POSTER SESSION ABSTRACTSBck1 f
- Page 235 and 236: FULL POSTER SESSION ABSTRACTSin the
- Page 237 and 238: FULL POSTER SESSION ABSTRACTS455. T
- Page 239 and 240: FULL POSTER SESSION ABSTRACTSor hos
- Page 241 and 242: FULL POSTER SESSION ABSTRACTSfragme
- Page 243 and 244: FULL POSTER SESSION ABSTRACTSenhanc
- Page 245 and 246: FULL POSTER SESSION ABSTRACTSassess
- Page 247: FULL POSTER SESSION ABSTRACTSmating
- Page 251 and 252: FULL POSTER SESSION ABSTRACTSOne of
- Page 253 and 254: FULL POSTER SESSION ABSTRACTScells
- Page 255 and 256: FULL POSTER SESSION ABSTRACTSof Ave
- Page 257 and 258: FULL POSTER SESSION ABSTRACTSascaro
- Page 259 and 260: FULL POSTER SESSION ABSTRACTSis a n
- Page 261 and 262: FULL POSTER SESSION ABSTRACTSand th
- Page 263 and 264: FULL POSTER SESSION ABSTRACTSCiuffe
- Page 265 and 266: FULL POSTER SESSION ABSTRACTSon oth
- Page 267 and 268: FULL POSTER SESSION ABSTRACTScopies
- Page 269 and 270: FULL POSTER SESSION ABSTRACTSChem.
- Page 271 and 272: FULL POSTER SESSION ABSTRACTS593. C
- Page 273 and 274: FULL POSTER SESSION ABSTRACTS601. P
- Page 275 and 276: FULL POSTER SESSION ABSTRACTSE.elym
- Page 277 and 278: FULL POSTER SESSION ABSTRACTSThe de
- Page 279 and 280: FULL POSTER SESSION ABSTRACTSMicrob
- Page 281 and 282: FULL POSTER SESSION ABSTRACTSchromo
- Page 283 and 284: FULL POSTER SESSION ABSTRACTSmating
- Page 285 and 286: FULL POSTER SESSION ABSTRACTSAt the
- Page 287 and 288: FULL POSTER SESSION ABSTRACTSemerge
- Page 289 and 290: FULL POSTER SESSION ABSTRACTS666. G
- Page 291 and 292: FULL POSTER SESSION ABSTRACTSof che
- Page 293 and 294: FULL POSTER SESSION ABSTRACTSthe lo
- Page 295 and 296: FULL POSTER SESSION ABSTRACTSin the
- Page 297 and 298: FULL POSTER SESSION ABSTRACTSpotent
- Page 299 and 300:
FULL POSTER SESSION ABSTRACTSpoint
- Page 301 and 302:
FULL POSTER SESSION ABSTRACTS716. p
- Page 303 and 304:
FULL POSTER SESSION ABSTRACTSnatura
- Page 305 and 306:
FULL POSTER SESSION ABSTRACTSelemen
- Page 307 and 308:
KEYWORD LISTABC proteins ..........
- Page 309 and 310:
KEYWORD LISThigh temperature growth
- Page 311 and 312:
AUTHOR LISTBolton, Melvin D. ......
- Page 313 and 314:
AUTHOR LISTFrancis, Martin ........
- Page 315 and 316:
AUTHOR LISTKawamoto, Susumu... 427,
- Page 317 and 318:
AUTHOR LISTNNadimi, Maryam ........
- Page 319 and 320:
AUTHOR LISTSenftleben, Dominik ....
- Page 321 and 322:
AUTHOR LISTYablonowski, Jacob .....
- Page 323 and 324:
LIST OF PARTICIPANTSLeslie G Beresf
- Page 325 and 326:
LIST OF PARTICIPANTSTim A DahlmannR
- Page 327 and 328:
LIST OF PARTICIPANTSIgor V Grigorie
- Page 329 and 330:
LIST OF PARTICIPANTSMasayuki KameiT
- Page 331 and 332:
LIST OF PARTICIPANTSGeorgiana MayUn
- Page 333 and 334:
LIST OF PARTICIPANTSNadia PontsINRA
- Page 335 and 336:
LIST OF PARTICIPANTSFrancis SmetUni
- Page 337 and 338:
LIST OF PARTICIPANTSAric E WiestUni